Geode Capital Management, LLC Intellia Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

$1.12 Trillion
Q2 2024

A detailed history of Geode Capital Management, LLC transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 2,293,943 shares of NTLA stock, worth $36.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,293,943

Previous 2,044,257 12.21%

Holding current value

$36.7 Million

Previous $56.2 Million 8.71%

% of portfolio

0.0%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$20.02 - $27.22 $5 Million - $6.8 Million	249,686 Added 12.21%	2,293,943 $51.3 Million
Q1 2024 May 13, 2024	BUY	$23.82 - $32.8 $1.69 Million - $2.33 Million	70,988 Added 3.6%	2,044,257 $56.2 Million
Q4 2023 Feb 13, 2024	BUY	$23.16 - $32.34 $2.15 Million - $3.01 Million	93,024 Added 4.95%	1,973,269 $60.2 Million
Q3 2023 Nov 13, 2023	BUY	$31.62 - $45.78 $2.98 Million - $4.32 Million	94,298 Added 5.28%	1,880,245 $59.5 Million
Q2 2023 Aug 11, 2023	BUY	$34.58 - $46.03 $4.51 Million - $6.01 Million	130,556 Added 7.89%	1,785,947 $72.8 Million
Q1 2023 May 15, 2023	BUY	$33.3 - $44.82 $2.12 Million - $2.85 Million	63,544 Added 3.99%	1,655,391 $61.7 Million
Q4 2022 Feb 13, 2023	BUY	$33.21 - $62.69 $7.23 Million - $13.6 Million	217,719 Added 15.84%	1,591,847 $55.5 Million
Q3 2022 Nov 14, 2022	BUY	$53.92 - $71.7 $4.4 Million - $5.85 Million	81,540 Added 6.31%	1,374,128 $76.9 Million
Q2 2022 Aug 12, 2022	BUY	$38.49 - $76.21 $2.53 Million - $5.01 Million	65,764 Added 5.36%	1,292,588 $66.9 Million
Q1 2022 May 13, 2022	SELL	$58.27 - $118.99 $330,274 - $674,435	-5,668 Reduced 0.46%	1,226,824 $89.2 Million
Q4 2021 Feb 11, 2022	BUY	$100.76 - $138.36 $3.57 Million - $4.9 Million	35,402 Added 2.96%	1,232,492 $146 Million
Q3 2021 Nov 12, 2021	BUY	$132.37 - $176.78 $10.4 Million - $13.8 Million	78,310 Added 7.0%	1,197,090 $161 Million
Q2 2021 Aug 13, 2021	BUY	$60.88 - $161.91 $5.95 Million - $15.8 Million	97,742 Added 9.57%	1,118,780 $181 Million
Q1 2021 May 12, 2021	BUY	$46.59 - $83.68 $7.39 Million - $13.3 Million	158,696 Added 18.4%	1,021,038 $81.9 Million
Q4 2020 Feb 12, 2021	BUY	$18.83 - $63.53 $2.28 Million - $7.68 Million	120,906 Added 16.31%	862,342 $46.9 Million
Q3 2020 Nov 13, 2020	BUY	$17.47 - $24.93 $1.5 Million - $2.15 Million	86,081 Added 13.14%	741,436 $14.7 Million
Q2 2020 Aug 13, 2020	BUY	$11.14 - $22.87 $716,457 - $1.47 Million	64,314 Added 10.88%	655,355 $13.8 Million
Q1 2020 May 14, 2020	BUY	$9.44 - $15.58 $400,992 - $661,807	42,478 Added 7.74%	591,041 $7.23 Million
Q4 2019 Feb 13, 2020	SELL	$10.43 - $17.67 $287,398 - $486,896	-27,555 Reduced 4.78%	548,563 $8.05 Million
Q3 2019 Nov 12, 2019	BUY	$13.07 - $18.51 $941,471 - $1.33 Million	72,033 Added 14.29%	576,118 $7.69 Million
Q2 2019 Aug 14, 2019	BUY	$13.88 - $18.41 $1.41 Million - $1.87 Million	101,726 Added 25.28%	504,085 $8.25 Million
Q1 2019 May 14, 2019	BUY	$12.79 - $17.62 $548,435 - $755,545	42,880 Added 11.93%	402,359 $6.87 Million
Q4 2018 Feb 13, 2019	BUY	$11.39 - $27.13 $202,411 - $482,127	17,771 Added 5.2%	359,479 $4.91 Million
Q3 2018 Nov 13, 2018	BUY	$25.78 - $32.6 $2.05 Million - $2.6 Million	79,623 Added 30.38%	341,708 $9.78 Million
Q2 2018 Aug 14, 2018	BUY	$20.02 - $30.79 $1.25 Million - $1.92 Million	62,295 Added 31.18%	262,085 $7.17 Million
Q1 2018 May 15, 2018	BUY	$19.43 - $34.95 $75,096 - $135,081	3,865 Added 1.97%	199,790 $4.21 Million
Q4 2017 Feb 13, 2018	BUY	$17.39 - $31.12 $1.02 Million - $1.82 Million	58,411 Added 42.48%	195,925 $3.77 Million
Q3 2017 Nov 14, 2017	BUY	$15.16 - $25.75 $665,690 - $1.13 Million	43,911 Added 46.91%	137,514 $3.42 Million
Q2 2017 Aug 14, 2017	BUY	N/A	93,603	93,603 $1.5 Million

Others Institutions Holding NTLA

# of Institutions

318

Shares Held

88.5M

Call Options Held

668K

Put Options Held

865K

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $1.22B
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Intellia Therapeutics, Inc. Transaction History